Skip to main content
Indo Borax & Chemicals Ltd. logo

Indo Borax & Chemicals Ltd. — Investor Relations & Filings

Ticker · INDOBORAX ISIN · INE803D01021 LEI · 254900WJGT4LTKPID068 BSE.NS Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2026-06-05 Call Transcript
Country IN India
Listing BSE.NS INDOBORAX

About Indo Borax & Chemicals Ltd.

https://www.indoborax.com/

Indo Borax & Chemicals Ltd. is a specialized manufacturer of boron-based chemicals, primarily focusing on the production of various grades of Boric Acid and Borax. The company's product portfolio includes Boric Acid in technical, pharmaceutical (IP/BP/USP), and agricultural grades, alongside Borax Decahydrate and Borax Pentahydrate. These products are utilized across diverse applications, including glass and ceramic manufacturing, micronutrient fertilizers, pharmaceutical formulations, and metallurgical processes. The company operates advanced manufacturing facilities to ensure high purity levels and adherence to stringent quality standards. Its chemicals are also integral to the production of flame retardants, wood preservatives, and specialized cleaning agents, supporting a broad range of industrial and commercial requirements.

Recent filings

Filing Released Lang Actions
Transcript of the Investor/Analyst Earnings Call held on Tuesday, June 2, 2026.
Call Transcript Classification · 95% confidence The document is titled “Transcript of the Investor/Analyst Earnings Call held on Tuesday, June 2, 2026” and consists of the full Q4 & FY2026 earnings conference call dialogue (management remarks and Q&A). This matches the definition of a Call Transcript (CT).
2026-06-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is the full transcript of the Q4 & FY2026 earnings conference call for Indo Borax & Chemicals Limited, including opening remarks, CFO presentation, and Q&A, submitted under SEBI LODR regulations. This matches the definition of a Call Transcript (CT).
2026-06-05 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 9% confidence The document is a statutory disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 31(4) declaring that no encumbrances have been created on the promoter’s equity shares. It is a routine regulatory filing, not a financial report, capital raising announcement, management change, or AGM material. Thus it falls under the catch-all Regulatory Filings category.
2026-06-05 English
Intimation of audio recording of Analysts/Institutional Investors/Organisations meet-''''Earnings Call''''.
Regulatory Filings Classification · 86% confidence The document is an intimation under Regulation 30 of the SEBI Listing Obligations, notifying stock exchanges that the audio recording link for the Q4 FY26 earnings call is available on the company’s website. It contains no financial data or report attachments; rather it is a regulatory announcement. This fits the “Regulatory Filings” category as a general compliance disclosure under Listing Regulations, not an earnings release or report itself.
2026-06-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 78% confidence The document is a formal intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying stock exchanges that the audio recording of the Q4FY26 earnings call is now available on the company website. It does not include any financial results, presentation materials, or a transcript of the call, but is purely a regulatory compliance notice to the exchanges. This falls under a general regulatory announcement category rather than a substantive earnings release, investor presentation, call transcript, or financial report. Therefore, the appropriate classification is a Regulatory Filing (RNS).
2026-06-02 English
Investor Presentation for the quarter and year ended March 31, 2026.
Investor Presentation Classification · 98% confidence The document is a letter to stock exchanges enclosing and presenting the actual Q4 & FY26 investor presentation, containing detailed slides on financial performance, strategy, management commentary, and forward-looking statements. This matches the “Investor Presentation” definition rather than a simple announcement or earnings release.
2026-05-28 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.